Joel Gemunder Net Worth

Joel Gemunder biography

Joel F. Gemunder serves as Independent Director of the Company. Mr. Gemunder’s experience, qualifications, attributes and skills include having served as President and Chief Executive Officer of Omnicare, Inc., Cincinnati, Ohio (healthcare products and services) (“Omnicare”). Omnicare, a former Fortune 500 Company acquired by CVS Health Corporation in 2015, is a leading provider of pharmaceutical and related services for seniors serving residents of skilled nursing, assisted living, and other healthcare facilities across the United States. He retired from these positions in August 2010, having served since May 1981 and May 2001, respectively. Omnicare is a former equity investee of the Company that became a publicly owned corporation in 1981 and has not been a Chemed affiliate since at least 1996. He was a director of Omnicare until his August 2010 retirement and a director of Ultratech, Inc. until his decision not to run for re-election at the 2016 meeting.

What is the salary of Joel Gemunder?

As the Independent Director of Chemed, the total compensation of Joel Gemunder at Chemed is $175,244. There are 14 executives at Chemed getting paid more, with Kevin McNamara having the highest compensation of $10,019,800.

How old is Joel Gemunder?

Joel Gemunder is 80, he's been the Independent Director of Chemed since 1977. There are 1 older and 18 younger executives at Chemed. The oldest executive at Chemed Corp. is Walter Krebs, 86, who is the Independent Director.

What's Joel Gemunder's mailing address?

Joel's mailing address filed with the SEC is 2600 CHEMED CENTER, 255 EAST 5TH STREET, CINCINNATI, OH, 45202.

Insiders trading at Chemed

Over the last 22 years, insiders at Chemed have traded over $138,634,486 worth of Chemed stock and bought 2,293 units worth $478,104 . The most active insiders traders include Kevin J Mcnamara, David Patrick Williams et Spencer S Lee. On average, Chemed executives and independent directors trade stock every 19 days with the average trade being worth of $4,438,497. The most recent stock trade was executed by Nicholas Michael Westfall on 9 September 2024, trading 1,713 units of CHE stock currently worth $975,297.

What does Chemed do?

chemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.

Chemed executives and stock owners

Chemed executives and other stock owners filed with the SEC include:

• Kevin McNamara,
  President, Chief Executive Officer, Director
• Kevin J. McNamara,
  CEO, Pres & Director
• David Williams,
  Chief Financial Officer, Executive Vice President
• Nicholas Westfall,
  Executive Vice President
• David P. Williams,
  Exec. VP & CFO
• Spencer Lee,
  Executive Vice President
• Nicholas Michael Westfall,
  Exec. VP
• Spencer S. Lee,
  Exec. VP
• Michael D. Witzeman CPA, MBA,
  VP & Controller
• George Walsh,
  Independent Chairman of the Board
• Patrick Grace,
  Independent Director
• Donald Saunders,
  Independent Director
• Thomas Rice,
  Independent Director
• Andrea Lindell,
  Independent Director
• Frank Wood,
  Independent Director
• Joel Gemunder,
  Independent Director
• Walter Krebs,
  Independent Director
• Thomas Hutton,
  Director
• Thomas C. Hutton,
  VP & Director
• Brian C. Judkins,
  VP, Sec. & Chief Legal Officer
• Sherri Warner,
  Director of Investor Relations
• Lisa A. Reinhard,
  VP, Chief Admin. Officer & Assistant Sec.
• Edward L Hutton,
  chairman of the board
• John Meredith Jr. Mount,
  
• Ron De Lyons,
  
• Christopher J Heaney,
  
• Eileen P Mc Carthy,
  
• Naomi C Dallob,
  VP and Chief Legal Officer
• Sandra E Laney,
  Director
• Donald Breen,
  Director
• Charles H Erhart,
  Director
• Arthur V Jr Tucker,
  vice president & controller
• Timothy S Otoole,
  executive vice president
• Asset Management Inc Et Al ...,
  10% owner
• Asset Management Inc Et Alg...,
  
• Michael D Witzeman,
  VP & Chief Financial Officer
• Brian C Judkins,
  VP and Chief Legal Officer